Depression and Anxiety Trial, Recruiting NCT07666776 Sponsor: Tel Aviv University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07666776
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years of age
  • People whose main diagnosis is generalised Social Anxiety Disorder, confirmed through a clinical evaluation, a structured psychiatric interview (called the MINI), and a score above 50 on a standard anxiety rating scale (called the LSAS)
  • People with normal vision, or vision that is fully corrected with glasses or contact lenses, and who do not have colour blindness
  • People with a sufficient level of Hebrew language ability to complete interviews, questionnaires, and computer-based tasks

Who may not be able to join:

  • People who have previously taken part in a type of attention training called dot-probe attention bias modification
  • People who have previously taken part in attention training that uses eye-tracking technology
  • People who currently have a diagnosis of Post-Traumatic Stress Disorder (PTSD)
  • People who currently have, or have previously been diagnosed with, a psychotic disorder or bipolar disorder
  • People who have a neurological condition, such as epilepsy or a brain injury
  • People who are experiencing severe thoughts of suicide
  • People who currently have a substance use or alcohol use disorder
  • People who are currently receiving medication or psychological treatment, unless their medication dose has been stable for at least 45 days (confirm with trial site)
  • People who are pregnant
  • People who have uncorrected vision problems, or who wear multifocal glasses

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yair Bar-Haim, PhD, Tel Aviv University

Phone: 97236405465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tel Aviv University
Registry
ClinicalTrials.gov
Start date
15 June 2026
Est. completion
30 October 2026

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Change in social anxiety symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov